AUB ScholarWorks

A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries: Results of the epidemiology of diabetes and ramadan 1422-2001 (EPIDIAR) study

Show simple item record

dc.contributor.author Salti I.
dc.contributor.author Benard E.
dc.contributor.author Detournay B.
dc.contributor.author Bianchi-Biscay M.
dc.contributor.author Le Brigand C.
dc.contributor.author Voinet C.
dc.contributor.author Jabbar A.
dc.contributor.editor
dc.date Oct-2004
dc.date.accessioned 2017-10-05T15:40:47Z
dc.date.available 2017-10-05T15:40:47Z
dc.date.issued 2004
dc.identifier 10.2337/diacare.27.10.2306
dc.identifier.isbn
dc.identifier.issn 01495992
dc.identifier.uri http://hdl.handle.net/10938/17642
dc.description.abstract OBJECTIVE - The aim of this study was to assess the characteristics and care of patients with diabetes in countries with a sizable Muslim population and to study diabetes features during Ramadan and the effect of fasting. RESEARCH DESIGN AND METHODS - This was a population-based, retrospective, transversal survey conducted in 13 countries. A total of 12,914 patients with diabetes were recruited using a stratified sampling method, and 12,243 were considered for the analysis. RESULTS - Investigators recruited 1,070 (8.7percent) patients with type 1 diabetes and 11,173 (91.3percent) patients with type 2 diabetes. During Ramadan, 42.8percent of patients with type 1 diabetes and 78.7percent with type 2 diabetes fasted for at least 15 days. Less than 50percent of the whole population changed their treatment dose (approximately one-fourth of patients treated with oral antidiabetic drugs [OADs] and one-third of patients using insulin). Severe hypoglycemic episodes were significantly more frequent during Ramadan compared with other months (type 1 diabetes, 0.14 vs. 0.03 episode-month, P = 0.0174; type 2 diabetes, 0.03 vs. 0.004 episode-month, P 0.0001). Severe hypoglycemia was more frequent in subjects who changed their dose of OADs or insulin or modified their level of physical activity. CONCLUSIONS - The large proportion of both type 1 and type 2 diabetic subjects who fast during Ramadan represent a challenge to their physicians. There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.
dc.format.extent
dc.format.extent Pages: (2306-2311)
dc.language English
dc.publisher ALEXANDRIA
dc.relation.ispartof Publication Name: Diabetes Care; Publication Year: 2004; Volume: 27; no. 10; Pages: (2306-2311);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title A population-based study of diabetes and its characteristics during the fasting month of ramadan in 13 countries: Results of the epidemiology of diabetes and ramadan 1422-2001 (EPIDIAR) study
dc.type Article
dc.contributor.affiliation Salti, I., Div. of Endocrinology and Metabolism, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Bénard, E., Cemka-Eval, Bourg La Reine, France
dc.contributor.affiliation Detournay, B., Cemka-Eval, Bourg La Reine, France
dc.contributor.affiliation Bianchi-Biscay, M., Aventis Pharma International, Antony, France, Aventis Intercontinental, 20 Ave. Raymond Aron, 92160 Antony, France
dc.contributor.affiliation Le Brigand, C., Alios Conseil, Paris, France
dc.contributor.affiliation Voinet, C., Cemka-Eval, Bourg La Reine, France
dc.contributor.affiliation Jabbar, A., Diabetes and Endocrinology Section, Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan
dc.contributor.authorAddress Bianchi-Biscay, M.; Aventis Intercontinental, 20 Ave. Raymond Aron, 92160 Antony, France; email: monique.bianchi-biscay@aventis.com
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; Division: Endocrinology;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision Endocrinology
dc.contributor.authorEmail monique.bianchi-biscay@aventis.com
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Salti, I
dc.contributor.authorInitials Benard, E
dc.contributor.authorInitials Detournay, B
dc.contributor.authorInitials Bianchi-Biscay, M
dc.contributor.authorInitials Le Brigand, C
dc.contributor.authorInitials Voinet, C
dc.contributor.authorInitials Jabbar, A
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Bianchi-Biscay, M (reprint author), Aventis Intercontinental, 20 Ave Raymond Aron, F-92160 Antony, France.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Akanji AO, 2000, EUR J CLIN NUTR, V54, P508, DOI 10.1038-sj.ejcn.1601047; Alwan A, 1992, World Health Stat Q, V45, P355; Mafauzy M, 1990, Med J Malaysia, V45, P14; Azizi F, 1998, INT J RAMADAN FASTIN, V2, P8; Azizi F, 1887, MED J IRI, V1, P38; BAGRAICIK N, 1994, 1 INT C HLTH RAM, P32; BELKHADIR J, 1993, BRIT MED J, V307, P292; BESSAOUD K, 1990, REV EPIDEMIOL SANTE, V38, P91; Bouguerra R, 1997, 2 INT C HLTH RAM, P33; CHEAH JS, 1990, ANN ACAD MED SINGAP, V4, P501; COCKRAM CS, 2000, KONG KONG MED J, V1, P43; DAVIDSON JC, 1979, BRIT MED J, V2, P1511; HAKKOU F, 1994, GASTROENTEROL CLIN B, V3, P190; HAOURI M, 1997, CIRCADIAN EVOLUTION, P31; HGOJLUND K, 2001, AM J PHYSIOL-ENDOC M, V1, pE50; *INT M DIAB RAM RE, 1995, HASS 2 FDN SCI MED R; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007-s00125-002-0858-x; Kadiki OA, 1998, DIABETES METAB, V24, P424; Kadiri A, 2001, DIABETES METAB, V27, P482; Katibi I A, 2001, Niger J Med, V10, P132; KHOGHEER Y, 1987, ANN SAUDI MED S, V7, P5; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337-diacare.21.9.1414; KING H, 1998, DIABETES CARE, V9, P414; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337-diacare.16.1.157; MAFAUZY M, 1990, MED J MALAYSIA, V1, P14; NIAZI G, 1997, 2 INT C HLTH RAM, P24; Ramadan J, 1999, NUTRITION, V15, P735, DOI 10.1016-S0899-9007(99)00145-8; Salti IS, 1997, E MEDITERR HLTH J, V3, P462; SATMAN I, 2002, DIABETES CARE, V825, P1551; Scott TG, 1981, KING ABDULAZIZ MED J, V1, P23; Southwell A, 1997, PRACTICAL DIABETES I, V14, P201, DOI 10.1002-pdi.1960140710; Uysal AR, 1998, DIABETES CARE, V21, P2033, DOI 10.2337-diacare.21.11.2033; Yarahmadi Sh, 2003, J Coll Physicians Surg Pak, V13, P329
dc.description.citedCount 143
dc.description.citedTotWOSCount 102
dc.description.citedWOSCount 100
dc.format.extentCount 6
dc.identifier.articleNo
dc.identifier.coden DICAD
dc.identifier.pubmedID 15451892
dc.identifier.scopusID 4644308445
dc.identifier.url
dc.publisher.address 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Diabetes Care
dc.relation.ispartOfIssue 10
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Diabetes Care
dc.relation.ispartofPubTitleAbbr Diabetes Care
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 27
dc.source.ID WOS:000224115700003
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS insulin, 9004-10-8
dc.subject.otherChemCAS Hypoglycemic Agents
dc.subject.otherChemCAS Insulin, 11061-68-0
dc.subject.otherIndex insulin
dc.subject.otherIndex oral antidiabetic agent
dc.subject.otherIndex adult
dc.subject.otherIndex article
dc.subject.otherIndex clinical feature
dc.subject.otherIndex controlled study
dc.subject.otherIndex diet restriction
dc.subject.otherIndex drug dose regimen
dc.subject.otherIndex female
dc.subject.otherIndex human
dc.subject.otherIndex hypoglycemia
dc.subject.otherIndex insulin dependent diabetes mellitus
dc.subject.otherIndex major clinical study
dc.subject.otherIndex male
dc.subject.otherIndex moslem
dc.subject.otherIndex non insulin dependent diabetes mellitus
dc.subject.otherIndex physical activity
dc.subject.otherIndex population and population related phenomena
dc.subject.otherIndex population research
dc.subject.otherIndex retrospective study
dc.subject.otherIndex time
dc.subject.otherIndex treatment outcome
dc.subject.otherIndex Adaptation, Physiological
dc.subject.otherIndex Age Distribution
dc.subject.otherIndex Aged
dc.subject.otherIndex Cohort Studies
dc.subject.otherIndex Diabetes Mellitus, Type 1
dc.subject.otherIndex Diabetes Mellitus, Type 2
dc.subject.otherIndex Diabetic Diet
dc.subject.otherIndex Fasting
dc.subject.otherIndex Female
dc.subject.otherIndex Follow-Up Studies
dc.subject.otherIndex Humans
dc.subject.otherIndex Hypoglycemia
dc.subject.otherIndex Hypoglycemic Agents
dc.subject.otherIndex Incidence
dc.subject.otherIndex Insulin
dc.subject.otherIndex Islam
dc.subject.otherIndex Life Style
dc.subject.otherIndex Male
dc.subject.otherIndex Middle Aged
dc.subject.otherIndex Multicenter Studies
dc.subject.otherIndex Pakistan
dc.subject.otherIndex Probability
dc.subject.otherIndex Retrospective Studies
dc.subject.otherIndex Risk Assessment
dc.subject.otherIndex Sex Distribution
dc.subject.otherKeywordPlus MELLITUS
dc.subject.otherKeywordPlus PREVALENCE
dc.subject.otherKeywordPlus MUSLIMS
dc.subject.otherWOS Endocrinology and Metabolism


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account